Immunome, Inc.
US ˙ NasdaqCM ˙ US45257U1088

SecurityIMNM / Immunome, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership188,229 shares
Latest Disclosed Value $ 4,116,568
Qube Research & Technologies Ltd ownership in IMNM / Immunome, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 188,229 shares of Immunome, Inc. (US:IMNM) valued at $4,116,568 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Immunome, Inc.. The current value of the position is $3,728,816 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOME COM 45257U108 188,229 188,229 4,117 0.0046
2026-02-17 2025-12-31 13F IMMUNOME COM 45257U108 0 -25,217 -100.00 0 -100.00
2025-11-14 2025-09-30 13F IMMUNOME COM 45257U108 25,217 25,217 295 0.0003
2025-05-15 2025-03-31 13F IMMUNOME COM 45257U108 0 -107,794 -100.00 0 -100.00
2025-02-14 2024-12-31 13F IMMUNOME COM 45257U108 107,794 -51,016 -32.12 1,145 -50.71 0.0015
2024-11-14 2024-09-30 13F IMMUNOME COM 45257U108 158,810 -234,592 -59.63 2,322 -51.24 0.0034
2024-08-14 2024-06-30 13F IMMUNOME COM 45257U108 393,402 -137,060 -25.84 4,760 -63.64 0.0075
2024-05-14 2024-03-31 13F IMMUNOME COM 45257U108 530,462 326,914 160.61 13,092 501.33 0.0208
2024-02-13 2023-12-31 13F IMMUNOME COM 45257U108 203,548 203,538 2,035,380.00 2,178 0.0042
2023-11-13 2023-09-30 13F IMMUNOME COM 45257U108 10 10 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.